Iradimed Corporation (NASDAQ:IRMD) Shares Purchased by Quest Partners LLC

Quest Partners LLC raised its holdings in shares of Iradimed Corporation (NASDAQ:IRMD) by 32.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,071 shares of the medical equipment provider’s stock after buying an additional 3,236 shares during the period. Quest Partners LLC’s holdings in Iradimed were worth $657,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Sequoia Financial Advisors LLC purchased a new stake in Iradimed during the 2nd quarter worth $568,000. Allspring Global Investments Holdings LLC boosted its position in shares of Iradimed by 14.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 20,122 shares of the medical equipment provider’s stock worth $1,012,000 after buying an additional 2,538 shares during the period. Albert D Mason Inc. acquired a new stake in shares of Iradimed in the third quarter valued at about $737,000. Algert Global LLC raised its holdings in shares of Iradimed by 84.1% during the 2nd quarter. Algert Global LLC now owns 26,774 shares of the medical equipment provider’s stock valued at $1,176,000 after buying an additional 12,227 shares during the period. Finally, Marshall Wace LLP acquired a new position in Iradimed during the 2nd quarter worth approximately $463,000. Institutional investors and hedge funds own 92.34% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Roth Mkm dropped their price objective on shares of Iradimed from $65.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd.

Iradimed Price Performance

Shares of Iradimed stock opened at $53.23 on Friday. Iradimed Corporation has a 1-year low of $40.05 and a 1-year high of $57.95. The business has a 50-day moving average of $51.02 and a 200-day moving average of $46.70. The company has a market capitalization of $674.58 million, a PE ratio of 36.46 and a beta of 0.79.

Iradimed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Friday, November 15th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.60 annualized dividend and a yield of 1.13%. Iradimed’s dividend payout ratio is presently 41.10%.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.